Raphas Co. Ltd (214260) - Total Liabilities

Latest as of March 2026: ₩42.41 Billion KRW ≈ $28.74 Million USD

Based on the latest financial reports, Raphas Co. Ltd (214260) has total liabilities worth ₩42.41 Billion KRW (≈ $28.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 214260 net assets growth trend to track the company's year-over-year net asset growth rate.

Raphas Co. Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Raphas Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Raphas Co. Ltd (214260) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Raphas Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Raphas Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Selangor Dredging Bhd KLSE:2224	Malaysia	RM616.84 Million
FLUOGUIDE A/S DK -1 F:96X	Germany	€33.76 Million
BII Railway Transportation Technology Holdings Company Limited F:CN6	Germany	€1.97 Billion
Sherritt International Corporation TO:S	Canada	CA$715.50 Million
Ionic Rare EARTHS Ltd AU:IXR	Australia	AU$2.97 Million
Steppe Cement F:ST9	Germany	€23.90 Million
LB Aluminium Bhd KLSE:9326	Malaysia	RM694.27 Million
Genie Music Corporation KQ:043610	Korea	₩115.36 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Raphas Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 214260 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.54	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Raphas Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Raphas Co. Ltd (2017–2025)

The table below shows the annual total liabilities of Raphas Co. Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩44.36 Billion ≈ $30.06 Million	-5.07%
2024-12-31	₩46.73 Billion ≈ $31.67 Million	-31.37%
2023-12-31	₩68.10 Billion ≈ $46.15 Million	+23.51%
2022-12-31	₩55.13 Billion ≈ $37.36 Million	+21.21%
2021-12-31	₩45.49 Billion ≈ $30.82 Million	+190.71%
2020-12-31	₩15.65 Billion ≈ $10.60 Million	+3.95%
2019-12-31	₩15.05 Billion ≈ $10.20 Million	+4.67%
2018-12-31	₩14.38 Billion ≈ $9.75 Million	+29.90%
2017-12-31	₩11.07 Billion ≈ $7.50 Million	--

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology

Market Cap

$50.26 Million

₩74.16 Billion KRW

Market Cap Rank

#21826 Global

#1290 in Korea

Share Price

₩8820.00

Change (1 day)

+6.78%

52-Week Range

₩6720.00 - ₩15500.00

All Time High

₩75400.00